Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma.
Acta Biomed
; 92(2): e2021205, 2021 05 12.
Article
in En
| MEDLINE
| ID: mdl-33988136
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Multiple Myeloma
Limits:
Humans
Language:
En
Journal:
Acta Biomed
Journal subject:
MEDICINA
Year:
2021
Document type:
Article
Country of publication: